su has been instrumental in positioning Mindray as an
internationally recognized, value-driven medical device company," said Mr. Xu
Hang, Mindray's Chairman and co-Chief Executive Officer. "On behalf of the
board of directors and Mindray, I want to personally thank Joyce for her
tremendous contributions to the company over the past several years. We are
fortunate to have Joyce remain with us as a director, and we will continue to
look to her for guidance and leadership."
Staying on as a director, Ms. Hsu will replace Mr. Ede on the compensation
committee and the nominations and corporate governance committee of Mindray's
board, effective immediately. Mr. Ede continues to serve on Mindray's board of
directors but does not serve on any of the board's committees. Ms. Hsu will
immediately begin working closely with Mr. Ede in the transition period
between now and May 1, 2009, when Mr. Ede takes on the CFO role. Ms. Hsu will
remain available in an advisory capacity after Mr. Ede takes the CFO position.
Mindray is a leading developer, manufacturer and marketer of medical
devices worldwide. Established in 1991, Mindray offers a broad range of
products across three primary business segments: patient monitoring & life
support products, in-vitro diagnostic products and medical imaging systems.
Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters
in Mahwah, New Jersey. Mindray also has another 12 international sales and
service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow,
Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver. For more information,
please visit http://www.mindray.com .
Page: 1 2 3 Related biology technology :1
|SOURCE Mindray Medical International Limited|
Copyright©2009 PR Newswire.
All rights reserved
. Mindray Announces 2008 Fourth Quarter and Full Year Results2
. Mindray Medical International Announces Second Quarter 2008 Results3
. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference4
. Mindray Medical International Announces First Quarter 2008 Results5
. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million6
. Mindray Medical International Announces Third Quarter 2007 Results7
. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director8
. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference9
. Savara Expands Board of Directors, Appoints Three New Members10
. Informed Medical Communications Appoints New Senior Manager, Strategic Operations11
. Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer